Showing 13,801 - 13,820 results of 34,782 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 0.89s Refine Results
  1. 13801

    Flexible Sheet-Type Sensor for Noninvasive Measurement of Cellular Oxygen Metabolism on a Culture Dish - Fig 3 by Mari Kojima (832141)

    Published 2015
    “…(c) SEM image of the sheet. Each microchamber has a 90 μm diameter and a 50 μm depth, and contains a 1-μm-thick sensing layer at its bottom. …”
  2. 13802

    Confocal images showing the BrdUimmunostaining in lectin-positive BV2 microglia (A,C,E,G; red). by Nimmi Baby (524594)

    Published 2014
    “…Nuclei are stained with DAPI. Scale bars: 50 µm. <b>I.</b> Quantitative analysis shows a significant decrease in number of BrdUimmunoreactive cells in activated microglia cultures transfected with Runx1t1siRNA for 24 h. …”
  3. 13803
  4. 13804

    Inferred trajectories of allele A under the simple dominant model (model No. 4 in Table 2) between 1980 and 1989. by Melanie Massaro (377591)

    Published 2013
    “…<p>The mean trajectory is shown by black line and the 50% and 95% confidence sets of the trajectories are shown in decreasing shades of grey. …”
  5. 13805
  6. 13806
  7. 13807

    Image 3_Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex.jpeg by Maria A. Colombatti Olivieri (21362615)

    Published 2025
    “…Also, low-dose TunR2 treatment of infected macrophages did not significantly decrease Map survival after 48 h of infection. These results suggest that TunR2 is not a good candidate to treat Map infections.…”
  8. 13808
  9. 13809

    Image 2_Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex.jpeg by Maria A. Colombatti Olivieri (21362615)

    Published 2025
    “…Also, low-dose TunR2 treatment of infected macrophages did not significantly decrease Map survival after 48 h of infection. These results suggest that TunR2 is not a good candidate to treat Map infections.…”
  10. 13810

    Image 1_Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex.jpeg by Maria A. Colombatti Olivieri (21362615)

    Published 2025
    “…Also, low-dose TunR2 treatment of infected macrophages did not significantly decrease Map survival after 48 h of infection. These results suggest that TunR2 is not a good candidate to treat Map infections.…”
  11. 13811

    Table 2_Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex.docx by Maria A. Colombatti Olivieri (21362615)

    Published 2025
    “…Also, low-dose TunR2 treatment of infected macrophages did not significantly decrease Map survival after 48 h of infection. These results suggest that TunR2 is not a good candidate to treat Map infections.…”
  12. 13812

    Table 1_Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex.docx by Maria A. Colombatti Olivieri (21362615)

    Published 2025
    “…Also, low-dose TunR2 treatment of infected macrophages did not significantly decrease Map survival after 48 h of infection. These results suggest that TunR2 is not a good candidate to treat Map infections.…”
  13. 13813
  14. 13814

    Gender and T cell responses. by Annemarie Namuniina (16496648)

    Published 2023
    “…The rates of cross-reactive T-cell populations in this exploratory Ugandan population appears higher than previous estimates from resource-rich countries like the United States (20–50% reactivity). It is unclear what role, if any, this cross-reactivity played in decreasing COVID-19 related mortality in Uganda and other African countries, but does suggest that a better understanding of global pre-existing immunological cross-reactivity could be an informative data of epidemiological intelligence moving forward.…”
  15. 13815

    Clade III N-AChR show similar agonist affinities. by Jennifer D. Noonan (14117157)

    Published 2022
    “…<p>Concentration- response curves were measured to determine if declining maximal response is due to decreasing ligand affinity. Concentration-response curves for clade III N-AChRs for (A) acetylcholine and (B) nicotine. …”
  16. 13816

    Rates of hospital admission stratified by gender. by Abdallah Y. Naser (4856113)

    Published 2024
    “…Rates of same-day hospital admission decreased by 13.3% [from 50.55 (95%CI 49.54–51.57) in 1998 to 43.81 (95%CI 43.00–44.63) in 2019 per 100,000 persons]. …”
  17. 13817

    Inhibition of AurA or HDAC6 by inhibitors preserves ciliary structure during porcine CoVs infection. by Tenghan Zhuang (22238809)

    Published 2025
    “…Tubacin treatment increased AcTub levels, while PHA-680632 (PHA) treatment decreased pAurA levels, indicating successful inhibition of AurA and HDAC6. …”
  18. 13818

    Image_1_Molecular mechanisms regulating natural menopause in the female ovary: a study based on transcriptomic data.jpeg by Quan Liu (486219)

    Published 2023
    “…Increased contents of terminally differentiated HMGB1+ Granulosa and GSTA1+ Granulosa were observed in the ovaries of individuals aged 50-69. Signaling pathway activity analysis indicated a gradual decrease in TGFb and MAPK pathway activity with menopause progression, while p53 pathway activity increased. …”
  19. 13819

    <b>Uncovering the role of the yeast lysine acetyltransferase NuA4 in the regulation of nuclear shape and lipid metabolism</b> by Sarah Laframboise (18338787)

    Published 2024
    “…Disruption of the NuA4 complex results in 70% of cells displaying nuclear deformations and nearly 50% of cells exhibiting vacuolar fragmentation. …”
  20. 13820

    Celecoxib activates SIRT1 in a biochemical, <i>in silico</i> and <i>in vitro</i> cell-based assay. by Madhavi Annamanedi (580922)

    Published 2014
    “…Right - Model showing the interactions of Celecoxib with SIRT1 protein. C. A representative Western blot showing a dose-dependent decrease of Ac-H3K9 levels in presence of celecoxib. * p-value<0.01 compared to Control. …”